Compare BFI Finance Indonesia Tbk (BFIN) vs Brigit Biofarmaka Teknologi Tbk. (OBAT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BFI Finance Indonesia Tbk vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? BFI Finance Indonesia Tbk trades at Rp915 (market cap 13.76T), while Brigit Biofarmaka Teknologi Tbk. trades at Rp242 (market cap 164.65B). The key difference: BFI Finance Indonesia Tbk is far larger — about 83.6× Brigit Biofarmaka Teknologi Tbk.'s market cap. Which is the better fit depends on your goals.
| BFIN | OBAT | |
|---|---|---|
Market Cap | 13.76T | 164.65B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About BFI Finance Indonesia Tbk
PT BFI Finance Indonesia Tbk (the Company) formerly PT. Bunas Finance Indonesia Tbk (the Company) was established as PT Manufacturers Hanover Leasing Indonesia on April 7, 1982 based on Notarial deed No. 57 of Kartini Muljadi, S.H., Notary in Jakarta. Presently, the Company is engaged in leasing, consumer financing and factoring of accounts receivable. And changed to BFI Finance Indonesia on 2001
Read more on BFIN →About Brigit Biofarmaka Teknologi Tbk.
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →
